Roxatidine is a novel, specific, competitive H 2 -receptor antagonist that is used to treat gastric and duodenal ulcers, and which is known to suppress the growth of several tumors by reducing vascular endothelial growth factor (VEGF) expression. Nevertheless, it remains unclear whether roxatidine h
β¦ LIBER β¦
Phenethyl isothiocyanate suppresses receptor activator of NF-kappaB ligand (RANKL)-induced osteoclastogenesis by blocking activation of ERK1/2 and p38 MAPK in RAW264.7 macrophages
β Scribed by Akira Murakami; Meiyu Song; Hajime Ohigashi
- Book ID
- 112010855
- Publisher
- IOS Press
- Year
- 2007
- Tongue
- English
- Weight
- 157 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0951-6433
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Roxatidine suppresses inflammatory respo
β
Eu-Jin Cho; Hyo-Jin An; Ji-Sun Shin; Hye-Eun Choi; Jane Ko; Young-Wuk Cho; Hyung
π
Article
π
2011
π
John Wiley and Sons
π
English
β 638 KB
Dioscorealide B suppresses LPS-induced n
β
Poonsit Hiransai; Suvina Ratanachaiyavong; Arunporn Itharat; Potchanapond Graidi
π
Article
π
2010
π
John Wiley and Sons
π
English
β 351 KB
## Abstract Dioscorealide B (DB), a naphthofuranoxepin has been purified from an ethanolic extract of the rhizome of __Dioscorea membranacea__ Pierre ex Prain & Burkill which has been used to treat inflammation and cancer in Thai Traditional Medicine. Previously, DB has been reported to have antiβi
Tanshinone IIA inhibits LPS-induced NF-ΞΊ
β
Seon Il Jang; Hyung Jin Kim; Young-Jun Kim; Seung-Il Jeong; Yong-Ouk You
π
Article
π
2006
π
Elsevier Science
π
English
β 586 KB
Ξ²1-Adrenergic receptor-mediated HO-1 ind
β
Yu Mi Ha; Sun Ah Ham; Young Min Kim; Young Soo Lee; Hye Jung Kim; Han Geuk Seo;
π
Article
π
2011
π
Elsevier Science
π
English
β 974 KB